Inhibitor Therapeutics, Inc. Interest and Other Income
Inhibitor Therapeutics, Inc. (INTI) reported Interest and Other Income of $4.66 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:InterestAndOtherIncome · last filed 2026-08-14
- Inhibitor Therapeutics, Inc. interest and other income for the quarter ending 2026-06-30 was $4.66K, a 86.98% decline year-over-year.
- Inhibitor Therapeutics, Inc. interest and other income for the quarter ending 2026-03-31 was $9.21K, a 77.92% decline year-over-year.
- Inhibitor Therapeutics, Inc. interest and other income for the quarter ending 2025-12-31 was $19.75K, a 68.35% decline year-over-year.
- Inhibitor Therapeutics, Inc. interest and other income for the quarter ending 2025-09-30 was $29.03K, a 64.70% decline year-over-year.
- Inhibitor Therapeutics, Inc. interest and other income for fiscal 2025 was $126.32K, a 60.30% decline from fiscal 2024.
- Inhibitor Therapeutics, Inc. interest and other income for fiscal 2024 was $318.21K, a 16.01% decline from fiscal 2023.
- Inhibitor Therapeutics, Inc. interest and other income for fiscal 2023 was $378.84K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.66K 10-Q · filed 2026-08-14 | $13.87K 10-Q · filed 2026-08-14 | $33.62K derived: sum of 3 quarters · filed 2026-08-14 | $62.65K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $9.21K 10-Q · filed 2026-05-15 | $28.96K derived: sum of 2 quarters · filed 2026-05-15 | $57.99K derived: sum of 3 quarters · filed 2026-05-15 | $93.82K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $19.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $48.78K derived: sum of 2 quarters · filed 2026-03-26 | $84.61K derived: sum of 3 quarters · filed 2026-08-14 | $126.32K 10-K · filed 2026-03-26 |
| 2025-09-30 | $29.03K 10-Q · filed 2025-11-13 | $64.86K derived: sum of 2 quarters · filed 2026-08-14 | $106.57K 10-Q · filed 2025-11-13 | $168.97K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $35.83K 10-Q · filed 2026-08-14 | $77.54K 10-Q · filed 2026-08-14 | $139.94K derived: sum of 3 quarters · filed 2026-08-14 | $222.18K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $41.70K 10-Q · filed 2026-05-15 | $104.11K derived: sum of 2 quarters · filed 2026-05-15 | $186.35K derived: sum of 3 quarters · filed 2026-05-15 | $269.81K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $62.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $144.65K derived: sum of 2 quarters · filed 2026-03-26 | $228.10K derived: sum of 3 quarters · filed 2026-03-26 | $318.21K 10-K · filed 2026-03-26 |
| 2024-09-30 | $82.24K 10-Q · filed 2025-11-13 | $165.70K derived: sum of 2 quarters · filed 2025-11-13 | $255.80K 10-Q · filed 2025-11-13 | $361.81K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $83.46K 10-Q · filed 2025-08-13 | $173.56K 10-Q · filed 2025-08-13 | $279.57K derived: sum of 3 quarters · filed 2025-08-13 | $374.34K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $90.11K 10-Q · filed 2025-05-14 | $196.11K derived: sum of 2 quarters · filed 2025-05-14 | $290.88K derived: sum of 3 quarters · filed 2025-05-14 | $378.82K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $106.01K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $200.78K derived: sum of 2 quarters · filed 2025-03-28 | $288.72K derived: sum of 3 quarters · filed 2025-03-28 | $378.84K 10-K · filed 2025-03-28 |
| 2023-09-30 | $94.77K 10-Q · filed 2024-11-12 | $182.71K derived: sum of 2 quarters · filed 2024-11-12 | $272.84K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $87.94K 10-Q · filed 2024-08-06 | $178.07K 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $90.13K 10-Q · filed 2024-05-13 |